☰

Ramzi A. Ockaili, Ph.D. - Publications

Affiliations: 
2003 Virginia Commonwealth University, Richmond, VA, United States 
Area:
Animal Physiology Biology, Pharmacology
Tree Info Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Samidurai A, Olex AL, Ockaili R, Kraskauskas D, Roh SK, Kukreja RC, Das A. Integrated Analysis of lncRNA-miRNA-mRNA Regulatory Network in Rapamycin-Induced Cardioprotection against Ischemia/Reperfusion Injury in Diabetic Rabbits. Cells. 12. PMID 38132140 DOI: 10.3390/cells12242820  0.471
2023 Samidurai A, Saravanan M, Ockaili R, Kraskauskas D, Lau SYV, Kodali V, Ramasamy S, Bhoopathi K, Nair M, Roh SK, Kukreja RC, Das A. Single-Dose Treatment with Rapamycin Preserves Post-Ischemic Cardiac Function through Attenuation of Fibrosis and Inflammation in Diabetic Rabbit. International Journal of Molecular Sciences. 24. PMID 37240345 DOI: 10.3390/ijms24108998  0.625
2021 Samidurai A, Ockaili R, Cain C, Roh SK, Filippone SM, Kraskauskas D, Kukreja RC, Das A. Preclinical model of type 1 diabetes and myocardial ischemia/reperfusion injury in conscious rabbits-demonstration of cardioprotection with rapamycin. Star Protocols. 2: 100772. PMID 34485939 DOI: 10.1016/j.xpro.2021.100772  0.59
2020 Samidurai A, Ockaili R, Cain C, Roh SK, Filippone SM, Kraskauskas D, Kukreja RC, Das A. Differential Regulation of mTOR Complexes with miR-302a Attenuates Myocardial Reperfusion Injury in Diabetes. Iscience. 23: 101863. PMID 33319180 DOI: 10.1016/j.isci.2020.101863  0.587
2018 Torrado J, Cain C, Mauro AG, Romeo F, Ockaili R, Chau VQ, Nestler JA, Devarakonda T, Ghosh S, Das A, Salloum FN. Sacubitril/Valsartan Averts Adverse Post-Infarction Ventricular Remodeling and Preserves Systolic Function in Rabbits. Journal of the American College of Cardiology. 72: 2342-2356. PMID 30384891 DOI: 10.1016/J.Jacc.2018.07.102  0.359
2015 Jones SP, Tang XL, Guo Y, Steenbergen C, Lefer DJ, Kukreja RC, Kong M, Li Q, Bhushan S, Zhu X, Du J, Nong Y, Stowers HL, Kondo K, Hunt GN, ... ... Ockaili R, et al. The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs. Circulation Research. 116: 572-86. PMID 25499773 DOI: 10.1161/Circresaha.116.305462  0.587
2014 Toldo S, Das A, Mezzaroma E, Chau VQ, Marchetti C, Durrant D, Samidurai A, Van Tassell BW, Yin C, Ockaili RA, Vigneshwar N, Mukhopadhyay ND, Kukreja RC, Abbate A, Salloum FN. Induction of microRNA-21 with exogenous hydrogen sulfide attenuates myocardial ischemic and inflammatory injury in mice. Circulation. Cardiovascular Genetics. 7: 311-20. PMID 24825878 DOI: 10.1161/Circgenetics.113.000381  0.62
2012 Das A, Salloum FN, Durrant D, Ockaili R, Kukreja RC. Rapamycin protects against myocardial ischemia-reperfusion injury through JAK2-STAT3 signaling pathway. Journal of Molecular and Cellular Cardiology. 53: 858-69. PMID 22999860 DOI: 10.1016/J.Yjmcc.2012.09.007  0.683
2012 Salloum FN, Das A, Samidurai A, Hoke NN, Chau VQ, Ockaili RA, Stasch JP, Kukreja RC. Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide. American Journal of Physiology. Heart and Circulatory Physiology. 302: H1347-54. PMID 22268103 DOI: 10.1152/Ajpheart.00544.2011  0.766
2012 Seropian IM, Abbate A, Toldo S, Harrington J, Smithson L, Ockaili R, Mezzaroma E, Damilano F, Hirsch E, Van Tassell BW. Pharmacologic inhibition of phosphoinositide 3-kinase gamma (PI3Kγ) promotes infarct resorption and prevents adverse cardiac remodeling after myocardial infarction in mice. Journal of Cardiovascular Pharmacology. 56: 651-8. PMID 20881611 DOI: 10.1097/Fjc.0B013E3181F9A905  0.473
2011 Kukreja RC, Salloum FN, Das A, Koka S, Ockaili RA, Xi L. Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases. Experimental and Clinical Cardiology. 16: e30-5. PMID 22131856  0.585
2009 Salloum FN, Chau VQ, Hoke NN, Abbate A, Varma A, Ockaili RA, Toldo S, Kukreja RC. Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide. Circulation. 120: S31-6. PMID 19752383 DOI: 10.1161/Circulationaha.108.843979  0.761
2009 Vandeput F, Krall J, Ockaili R, Salloum FN, Florio V, Corbin JD, Francis SH, Kukreja RC, Movsesian MA. cGMP-hydrolytic activity and its inhibition by sildenafil in normal and failing human and mouse myocardium. The Journal of Pharmacology and Experimental Therapeutics. 330: 884-91. PMID 19546307 DOI: 10.1124/Jpet.109.154468  0.589
2009 Kukreja RC, Chau VQ, Hoke NN, Abbate A, Varma A, Ockaili RA, Toldo S, Salloum FN. Phosphodiesterase-5 inhibition and cardioprotection: Potential role of hydrogen sulfide Bmc Pharmacology. 9. DOI: 10.1186/1471-2210-9-S1-S24  0.7
2007 Straino S, Salloum FN, Baldi A, Ockaili RA, Piro M, Das A, Qureshi IZ, Biasucci LM, Capogrossi MC, Biondi-Zoccai GG, Severino A, Mellone P, Crea F, Vetrovec GW, Kukreja RC, et al. Protective effects of parecoxib, a cyclo-oxygenase-2 inhibitor, in postinfarction remodeling in the rat. Journal of Cardiovascular Pharmacology. 50: 571-7. PMID 18030068 DOI: 10.1097/Fjc.0B013E31814B91Cb  0.73
2007 Abbate A, Salloum FN, Ockaili RA, Fowler AA, Biondi-Zoccai GG, Straino S, Lipinski MJ, Baldi A, Crea F, Biasucci LM, Vetrovec GW, Kukreja RC. Improvement of cardiac function with parecoxib, a cyclo-oxygenase-2 inhibitor, in a rat model of ischemic heart failure. Journal of Cardiovascular Pharmacology. 49: 416-8. PMID 17577107 DOI: 10.1097/Fjc.0B013E31804A5E50  0.589
2007 Salloum FN, Takenoshita Y, Ockaili RA, Daoud VP, Chou E, Yoshida K, Kukreja RC. Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits. Journal of Molecular and Cellular Cardiology. 42: 453-8. PMID 17157308 DOI: 10.1016/J.Yjmcc.2006.10.015  0.648
2006 Salloum FN, Ockaili RA, Wittkamp M, Marwaha VR, Kukreja RC. Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits. Journal of Molecular and Cellular Cardiology. 40: 405-11. PMID 16480739 DOI: 10.1016/J.Yjmcc.2005.10.002  0.679
2005 Kukreja RC, Salloum F, Das A, Ockaili R, Yin C, Bremer YA, Fisher PW, Wittkamp M, Hawkins J, Chou E, Kukreja AK, Wang X, Marwaha VR, Xi L. Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications. Vascular Pharmacology. 42: 219-32. PMID 15922255 DOI: 10.1016/J.Vph.2005.02.010  0.634
2005 Ockaili R, Natarajan R, Salloum F, Fisher BJ, Jones D, Fowler AA, Kukreja RC. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. American Journal of Physiology. Heart and Circulatory Physiology. 289: H542-8. PMID 15805230 DOI: 10.1152/Ajpheart.00089.2005  0.63
2005 Bremer YA, Salloum F, Ockaili R, Chou E, Moskowitz WB, Kukreja RC. Sildenafil citrate (viagra) induces cardioprotective effects after ischemia/reperfusion injury in infant rabbits. Pediatric Research. 57: 22-7. PMID 15531735 DOI: 10.1203/01.Pdr.0000147736.27672.15  0.634
2004 Das A, Ockaili R, Salloum F, Kukreja RC. Protein kinase C plays an essential role in sildenafil-induced cardioprotection in rabbits. American Journal of Physiology. Heart and Circulatory Physiology. 286: H1455-60. PMID 15020304 DOI: 10.1152/Ajpheart.01040.2003  0.659
2004 Kukreja RC, Ockaili R, Salloum F, Yin C, Hawkins J, Das A, Xi L. Cardioprotection with phosphodiesterase-5 inhibition--a novel preconditioning strategy. Journal of Molecular and Cellular Cardiology. 36: 165-73. PMID 14871543 DOI: 10.1016/J.Yjmcc.2003.11.001  0.626
2004 Bremer YA, Salloum F, Ockaili R, Chou EJ, Moskowitz WB, Kukreja RC. 1041-95 Sildenafil citrate (viagra) induces powerful cardioprotective effects following ischemia-reperfusion injury in infant rabbits Journal of the American College of Cardiology. 43: A256. DOI: 10.1016/S0735-1097(04)91087-X  0.594
2003 Kukreja RC, Ockaili R, Salloum F, Xi L. Sildenafil-induced cardioprotection in rabbits. Cardiovascular Research. 60: 700-1; author reply . PMID 14659816 DOI: 10.1016/J.Cardiores.2003.10.002  0.641
2002 Ockaili R, Salloum F, Hawkins J, Kukreja RC. Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits. American Journal of Physiology. Heart and Circulatory Physiology. 283: H1263-9. PMID 12181158 DOI: 10.1152/Ajpheart.00324.2002  0.634
2001 Kositprapa C, Ockaili RA, Kukreja RC. Bradykinin B2 receptor is involved in the late phase of preconditioning in rabbit heart. Journal of Molecular and Cellular Cardiology. 33: 1355-62. PMID 11437541 DOI: 10.1006/Jmcc.2000.1396  0.59
2001 Ockaili RA, Bhargava P, Kukreja RC. Chemical preconditioning with 3-nitropropionic acid in hearts: role of mitochondrial K(ATP) channel. American Journal of Physiology. Heart and Circulatory Physiology. 280: H2406-11. PMID 11299248 DOI: 10.1152/Ajpheart.2001.280.5.H2406  0.619
1999 Ockaili R, Emani VR, Okubo S, Brown M, Krottapalli K, Kukreja RC. Opening of mitochondrial Kchannel induces early and delayed cardioprotective effect: role of nitric oxide. American Journal of Physiology. Heart and Circulatory Physiology. 277: H2425-H2434. PMID 29592265 DOI: 10.1152/ajpheart.1999.277.6.H2425  0.551
1999 Ockaili R, Emani VR, Okubo S, Brown M, Krottapalli K, Kukreja RC. Opening of mitochondrial K(ATP) channel induces early and delayed cardioprotective effect: Role of nitric oxide American Journal of Physiology - Heart and Circulatory Physiology. 277. PMID 10600865 DOI: 10.1152/Ajpheart.1999.277.6.H2425  0.594
Show low-probability matches.